Analysis: The potential health and economic impact of dexamethasone treatment for patients with COVID-19
View ORCID ProfileRicardo Águas, Adam Mahdi, Rima Shretta, Peter Horby, Martin Landray, Lisa White, the CoMo Consortium
doi: https://doi.org/10.1101/2020.07.29.20164269
Ricardo Águas
1University of Oxford
Adam Mahdi
1University of Oxford
Rima Shretta
1University of Oxford
Peter Horby
1University of Oxford
Martin Landray
1University of Oxford
Lisa White
1University of Oxford
1University of Oxford
Data Availability
all used data is oublicly available
Posted July 30, 2020.
Analysis: The potential health and economic impact of dexamethasone treatment for patients with COVID-19
Ricardo Águas, Adam Mahdi, Rima Shretta, Peter Horby, Martin Landray, Lisa White, the CoMo Consortium
medRxiv 2020.07.29.20164269; doi: https://doi.org/10.1101/2020.07.29.20164269
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2855)
- Dermatology (244)
- Emergency Medicine (430)
- Epidemiology (12563)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4437)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2851)
- Health Policy (1049)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4196)
- Nursing (222)
- Nutrition (617)
- Oncology (2204)
- Ophthalmology (624)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (269)
- Palliative Medicine (82)
- Pathology (486)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6784)
- Radiology and Imaging (1490)
- Respiratory Medicine (900)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)